Overview

VX-950 and Peginterferon for Hepatitis C

Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
VX-950 is an investigational drug , which is being tested in combination with a known treatment for hepatitis C, peginterferon.
Phase:
Phase 1
Details
Lead Sponsor:
Vertex Pharmaceuticals Incorporated